 |
27 Diseases |  |
22 Trials |
|
22 Trials |  |
341 News |  |
| «1234567» |
- bupropion sustained-release / Generic mfg.
Enrollment open: Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers (clinicaltrials.gov) - Feb 23, 2015
P=N/A, N=165, Recruiting, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Recruiting
- |||| Chantix (varenicline) / Pfizer
Enrollment open: Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (clinicaltrials.gov) - Feb 9, 2015
P4, N=6800, Recruiting, Sponsor: Pfizer
Not yet recruiting --> Recruiting Active, not recruiting --> Recruiting
- Chantix (varenicline) / Pfizer
Trial primary completion date, Real-world evidence, Real-world effectiveness, Real-world: The MATCH (Medication Aids for Tobacco Cessation and Health) Study (clinicaltrials.gov) - Feb 3, 2015
P=N/A, N=1500, Recruiting, Sponsor: Centre for Addiction and Mental Health
Active, not recruiting --> Recruiting Trial primary completion date: Sep 2014 --> Sep 2015
- Chantix (varenicline) / Pfizer
Biomarker, Trial primary completion date: Pharmacogenetics, Emotional Reactivity and Smoking (clinicaltrials.gov) - Jan 29, 2015
P2/3, N=375, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Sep 2014 --> Sep 2015 Trial primary completion date: Dec 2015 --> Dec 2016
- ||| Chantix (varenicline) / Pfizer
Enrollment closed: Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (clinicaltrials.gov) - Jan 9, 2015
P4, N=6800, Active, not recruiting, Sponsor: Pfizer
Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Active, not recruiting
- bupropion sustained-release / Generic mfg.
Enrollment closed, Trial primary completion date: QUIT4EVER: Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD (clinicaltrials.gov) - Jan 8, 2015
P=N/A, N=30, Active, not recruiting, Sponsor: Duke University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> May 2015
- Chantix (varenicline) / Pfizer
Clinical: Randomized Clinical Trial to Reduce Harm From Tobacco (clinicaltrials.gov) - Jan 2, 2015
P=N/A, N=6000, Not yet recruiting, Sponsor: University of Pennsylvania
- aripiprazole / Generic mfg., bupropion sustained-release / Generic mfg.
Trial primary completion date: VAST-D: VA Augmentation and Switching Treatments for Improving Depression Outcomes (clinicaltrials.gov) - Dec 30, 2014
P3, N=1518, Recruiting, Sponsor: Department of Veterans Affairs
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> May 2015 Trial primary completion date: Apr 2015 --> Jul 2015
- Chantix (varenicline) / Pfizer
Enrollment change, Trial termination: LiveForLife2: Tailored Smoking Cessation Treatment for LIVE FOR LIFE (clinicaltrials.gov) - Dec 25, 2014
P2/3, N=19, Terminated, Sponsor: Duke University
Trial primary completion date: Apr 2015 --> Jul 2015 N=300 --> 19 | Active, not recruiting --> Terminated; Low Recruitment
- ||||||| bupropion sustained-release / Generic mfg.
Trial completion, Trial primary completion date: Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects (clinicaltrials.gov) - Dec 12, 2014
P3, N=242, Completed, Sponsor: Orexigen Therapeutics, Inc
N=300 --> 19 | Active, not recruiting --> Terminated; Low Recruitment Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Sep 2014
- bupropion sustained-release / Generic mfg.
Enrollment change: Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers (clinicaltrials.gov) - Nov 25, 2014
P4, N=197, Completed, Sponsor: Southern Illinois University Carbondale
Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Sep 2014 N=125 --> 197
- | New P4 trial: Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects (clinicaltrials.gov) - Nov 14, 2014
P4, N=126, Not yet recruiting, Sponsor: Centre hospitalier de l'Universit
- ||| Chantix (varenicline) / Pfizer
Trial initiation date: Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (clinicaltrials.gov) - Nov 4, 2014
P4, N=6800, Recruiting, Sponsor: Pfizer
N=125 --> 197 Initiation date: Jan 2012 --> May 2012
- bupropion sustained-release / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy (clinicaltrials.gov) - Oct 17, 2014
P2, N=12, Completed, Sponsor: The University of Texas Health Science Center, Houston
Initiation date: Jan 2012 --> May 2012 Active, not recruiting --> Completed | N=50 --> 12 | Trial primary completion date: Apr 2014 --> Oct 2012
- ||| Chantix (varenicline) / Pfizer
Phase classification, Trial initiation date, Trial primary completion date: Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (clinicaltrials.gov) - Oct 10, 2014
P4, N=6800, Recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed | N=50 --> 12 | Trial primary completion date: Apr 2014 --> Oct 2012 Phase classification: P=N/A --> P4 | Initiation date: May 2012 --> Jan 2012 | Trial primary completion date: Apr 2017 --> Jul 2015
- |||| Chantix (varenicline) / Pfizer
Trial primary completion date: Combining Varenicline and Bupropion for Smoking Cessation (clinicaltrials.gov) - Sep 28, 2014
P3, N=385, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Phase classification: P=N/A --> P4 | Initiation date: May 2012 --> Jan 2012 | Trial primary completion date: Apr 2017 --> Jul 2015 Trial primary completion date: Aug 2015 --> Aug 2016
- bupropion sustained-release / Generic mfg., fluoxetine / Generic mfg.
New P4 trial: Bupropion for Depression in ESRD Patients on Hemodialysis (clinicaltrials.gov) - Sep 12, 2014
P4, N=40, Not yet recruiting, Sponsor: University of Arkansas
- | Chantix (varenicline) / Pfizer
Phase classification: Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (clinicaltrials.gov) - Sep 9, 2014
P=N/A, N=8000, Recruiting, Sponsor: Pfizer
Trial primary completion date: Aug 2015 --> Aug 2016 Phase classification: P4 --> P=N/A
- bupropion sustained-release / Generic mfg.
Trial completion, Trial primary completion date: Integrated Smoking Cessation Treatment for Low Income Community Corrections (clinicaltrials.gov) - Aug 5, 2014
P=N/A, N=689, Completed, Sponsor: University of Alabama at Birmingham
Phase classification: P4 --> P=N/A Active, not recruiting --> Completed | Trial primary completion date: Sep 2014 --> Mar 2014
- bupropion sustained-release / Generic mfg.
Enrollment open: QUIT4EVER: Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD (clinicaltrials.gov) - Jul 2, 2014
P=N/A, N=30, Recruiting, Sponsor: Duke University
Active, not recruiting --> Completed | Trial primary completion date: Sep 2014 --> Mar 2014 Not yet recruiting --> Recruiting
- bupropion ER / Generic mfg.
New P4 trial, Surgery, Bariatric surgery: A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery (clinicaltrials.gov) - Jun 27, 2014
P4, N=20, Recruiting, Sponsor: North Dakota State University
- | bupropion sustained-release / Generic mfg.
New P4 trial: Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease (clinicaltrials.gov) - Jun 13, 2014
P4, N=100, Recruiting, Sponsor: University of Pittsburgh
- Chantix (varenicline) / Pfizer
Enrollment open, Real-world evidence, Real-world effectiveness, Real-world: The MATCH (Medication Aids for Tobacco Cessation and Health) Study (clinicaltrials.gov) - Jun 5, 2014
P=N/A, N=1500, Recruiting, Sponsor: Centre for Addiction and Mental Health
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- bupropion sustained-release / Generic mfg.
Trial primary completion date: Bupropion for Smoking Cessation During Pregnancy (clinicaltrials.gov) - Jun 4, 2014
P4, N=150, Recruiting, Sponsor: The University of Texas, Galveston
Not yet recruiting --> Recruiting Trial primary completion date: Oct 2014 --> Apr 2015
- Chantix (varenicline) / Pfizer
Real-world evidence, Real-world effectiveness, Real-world: The MATCH (Medication Aids for Tobacco Cessation and Health) Study (clinicaltrials.gov) - May 22, 2014
P=N/A, N=1500, Not yet recruiting, Sponsor: Centre for Addiction and Mental Health
- Chantix (varenicline) / Pfizer
Trial primary completion date: Extended Treatment for Smoking Cessation (clinicaltrials.gov) - May 11, 2014
P=N/A, N=400, Active, not recruiting, Sponsor: Stanford University
Trial primary completion date: Oct 2014 --> Apr 2015 Trial primary completion date: Mar 2014 --> Mar 2015
- Chantix (varenicline) / Pfizer
Trial completion date: Extended Treatment for Smoking Cessation (clinicaltrials.gov) - May 11, 2014
P=N/A, N=400, Active, not recruiting, Sponsor: Stanford University
Trial primary completion date: Mar 2014 --> Mar 2015 Trial completion date: Mar 2014 --> Mar 2015
- Chantix (varenicline) / Pfizer
Enrollment closed: Extended Treatment for Smoking Cessation (clinicaltrials.gov) - May 11, 2014
P=N/A, N=400, Active, not recruiting, Sponsor: Stanford University
Trial completion date: Mar 2014 --> Mar 2015 Recruiting --> Active, not recruiting
- | NN1213 / Novo Nordisk
Trial completion: Comparing Smoking Treatment Programs for Lighter Smokers - 1 (clinicaltrials.gov) - Apr 9, 2014
P2, N=260, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Chantix (varenicline) / Pfizer
Enrollment closed: ConNicBrain: Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation (clinicaltrials.gov) - Mar 25, 2014
P3, N=1000, Active, not recruiting, Sponsor: Duke University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- bupropion sustained-release / Generic mfg.
Trial suspension: Contingency Management for Smoking Cessation in Homeless Smokers (clinicaltrials.gov) - Mar 10, 2014
P=N/A, N=30, Suspended, Sponsor: Duke University
Recruiting --> Active, not recruiting Recruiting --> Suspended
- | NN1213 / Novo Nordisk
Trial completion: Brain Reaction to Treatment of Nicotine Dependence (clinicaltrials.gov) - Feb 22, 2014
P1, N=104, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Suspended Recruiting --> Completed
- || Chantix (varenicline) / Pfizer
New P3 trial: Web-based Smoking Cessation Program for Tribal College Students (clinicaltrials.gov) - Jan 28, 2014
P3, N=300, Not yet recruiting, Sponsor: Won Choi, PhD, MPH
- bupropion sustained-release / Generic mfg., armodafinil / Generic mfg., minocycline extended release / Generic mfg.
Trial termination: Symptom Burden in Head and Neck Cancer (clinicaltrials.gov) - Jan 14, 2014
P1/2, N=1, Terminated, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed Recruiting --> Terminated; Low accrual.
- bupropion sustained-release / Generic mfg., armodafinil / Generic mfg., minocycline extended release / Generic mfg.
Enrollment change: Symptom Burden in Head and Neck Cancer (clinicaltrials.gov) - Jan 14, 2014
P1/2, N=1, Terminated, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Terminated; Low accrual. N=32 --> 1
- methamphetamine / Generic mfg.
Biomarker, Trial completion: BUP PGx: Study of Medical Treatment for Methamphetamine Addiction (clinicaltrials.gov) - Jan 9, 2014
P2, N=84, Completed, Sponsor: University of California, Los Angeles
N=32 --> 1 Active, not recruiting --> Completed
- bupropion sustained-release / Generic mfg.
Trial initiation date: CPT and Smoking Cessation (clinicaltrials.gov) - Dec 11, 2013
P2/3, N=50, Recruiting, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed Initiation date: Sep 2013 --> Dec 2013
- bupropion sustained-release / Generic mfg.
Enrollment open: CPT and Smoking Cessation (clinicaltrials.gov) - Dec 11, 2013
P2/3, N=50, Recruiting, Sponsor: Department of Veterans Affairs
Initiation date: Sep 2013 --> Dec 2013 Not yet recruiting --> Recruiting
- bupropion sustained-release / Generic mfg.
Trial completion: Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With SMI (clinicaltrials.gov) - Nov 11, 2013
P=N/A, N=61, Completed, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Completed
- bupropion sustained-release / Generic mfg.
Trial completion: Influence of Bupropion on the Effects of MDMA (clinicaltrials.gov) - Oct 13, 2013
P1, N=16, Completed, Sponsor: University Hospital, Basel, Switzerland
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Chantix (varenicline) / Pfizer
Enrollment change: ConNic4: Concurrent Bupropion / Varenicline for Smoking Cessation (clinicaltrials.gov) - Sep 24, 2013
P3, N=702, Completed, Sponsor: Duke University
Active, not recruiting --> Completed N=1500 --> 702
- | Chantix (varenicline) / Pfizer
Trial completion: ConNic4: Concurrent Bupropion / Varenicline for Smoking Cessation (clinicaltrials.gov) - Sep 24, 2013
P3, N=702, Completed, Sponsor: Duke University
N=1500 --> 702 Active, not recruiting --> Completed
- | Chantix (varenicline) / Pfizer
Enrollment closed: Combining Varenicline and Bupropion for Smoking Cessation (clinicaltrials.gov) - Aug 1, 2013
P3, N=385, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- bupropion sustained-release / Generic mfg.
New P2/3 trial: CPT and Smoking Cessation (clinicaltrials.gov) - Jul 15, 2013
P2/3, N=50, Recruiting, Sponsor: Department of Veterans Affairs
- || Chantix (varenicline) / Pfizer
New P3 trial: Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers (clinicaltrials.gov) - Jul 2, 2013
P3, N=500, Not yet recruiting, Sponsor: University of Iowa
- ||||| Chantix (varenicline) / Pfizer
Enrollment closed: LiveForLife2: Tailored Smoking Cessation Treatment for LIVE FOR LIFE (clinicaltrials.gov) - Jun 27, 2013
P2/3, N=300, Active, not recruiting, Sponsor: Duke University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- bupropion sustained-release / Generic mfg.
Enrollment closed: Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy (clinicaltrials.gov) - Jun 23, 2013
P2, N=50, Active, not recruiting, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- bupropion sustained-release / Generic mfg.
Enrollment closed: Integrated Smoking Cessation Treatment for Low Income Community Corrections (clinicaltrials.gov) - Jun 19, 2013
P=N/A, N=600, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- bupropion sustained-release / Generic mfg.
Trial completion: Nicotine Patch Pretreatment for Smoking Cessation in PTSD (clinicaltrials.gov) - Jun 19, 2013
P0, N=87, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- bupropion sustained-release / Generic mfg.
Trial completion: Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers (clinicaltrials.gov) - Jun 11, 2013
P4, N=125, Completed, Sponsor: Southern Illinois University Carbondale
Active, not recruiting --> Completed Active, not recruiting --> Completed